No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. (Q51589277)
Jump to navigation
Jump to search
scientific article published on 21 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. |
scientific article published on 21 March 2011 |
Statements
No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. (English)
1 reference
1 reference
Viola Heinzelmann-Schwarz
1 reference
Mara Meier
1 reference
Rosmarie Caduff
1 reference
Darlene Goldstein
1 reference
Tatiana Pochechueva
1 reference
Neville Hacker
1 reference
Daniel Fink
1 reference
21 March 2011
1 reference
121
1 reference
3
1 reference
487-491
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference